Northwestern Mutual Wealth Management
RPRX icon

Northwestern Mutual Wealth Management’s Royalty Pharma RPRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
30,218
+237
+0.8% +$12.3K ﹤0.01% 1225
2026
Q1 		$1.44M Buy
29,981
+13,303
+80% +$583K ﹤0.01% 1214
2025
Q4 		$644K Buy
16,678
+5,958
+56% +$227K ﹤0.01% 1443
2025
Q3 		$378K Buy
10,720
+792
+8% +$28.7K ﹤0.01% 1548
2025
Q2 		$358K Buy
9,928
+2,303
+30% +$76.3K ﹤0.01% 1518
2025
Q1 		$237K Buy
7,625
+1,151
+18% +$36.5K ﹤0.01% 1595
2024
Q4 		$165K Buy
6,474
+2,805
+76% +$74.4K ﹤0.01% 1738
2024
Q3 		$104K Buy
3,669
+3,653
+22,831% +$101K ﹤0.01% 1882
2024
Q2 		$422 Sell
16
-44
-73% -$1.22K ﹤0.01% 3309
2024
Q1 		$1.82K Buy
+60
New +$1.77K ﹤0.01% 3072
2023
Q4 		– Sell
-71
Closed -$1.93K – 3650
2023
Q3 		$1.93K Buy
71
+12
+20% +$356 ﹤0.01% 2956
2023
Q2 		$1.81K Buy
59
+56
+1,867% +$1.9K ﹤0.01% 3002
2023
Q1 		$108 Sell
3
-188
-98% -$6.97K ﹤0.01% 3241
2022
Q4 		$7.55K Buy
+191
New +$7.97K ﹤0.01% 2599
2022
Q2 		– Sell
-2
Closed – – 3430
2022
Q1 		$0 Buy
+2
New +$79 ﹤0.01% 3355
2021
Q4 		– Sell
-750
Closed -$27K – 3302
2021
Q3 		$27K Buy
750
+747
+24,900% +$29K ﹤0.01% 2111
2021
Q2 		$0 Hold
3
– – ﹤0.01% 3136
2021
Q1 		$0 Sell
3
-1
-25% -$47 ﹤0.01% 2940
2020
Q4 		$0 Buy
+4
New +$170 ﹤0.01% 2850

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northwestern Mutual Wealth Management's RPRX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Royalty Pharma (RPRX) stake by 0.79% in Q2 2026, buying an estimated $12.3K and bringing the position to 30,218 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Northwestern Mutual Wealth Management first reported a position in RPRX in Q4 2020 and has held it in 19 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 30,218 shares of Royalty Pharma worth $1.69M as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 237 Royalty Pharma shares in Q2 2026, an estimated $12.3K.
  • Royalty Pharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1225 holding.
  • Northwestern Mutual Wealth Management first reported a position in Royalty Pharma in Q4 2020 and has held it in 19 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.